Home›Companies›Healthcare›NKA Bio

NKA Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 3, 2023·Suggest an edit

About NKA Bio

NKA Bio is a private company based in Baltimore, Maryland, incorporated in 2023 in Delaware. It has reported $30,000 raised in one offering on Form D since April 2023. Its chief executive is Susan Hibbs.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 21, 2023Apr 3, 2023$30,000of $2.0M target3$10,000EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on NKA Bio's Form D filed Apr 3, 2023.

LH
Lewis Hibbs
Executive officer and director
LJ
Les Johnson
Executive officer and director
SH
Susan Hibbs
Chief Executive Officer and director

Sources

  1. SECNKA Bio, Inc. filing history